UM

Urvi Manish Kothari

Active Director Director DIN 08544123
DIN 08544123 First appointment Aug 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Urvi Manish Kothari

Data last updated:

Urvi Manish Kothari is a Director at Flokem Pharma Private Limited (since 2019). The company operates in Healthcare. Flokem Pharma Private Limited reported revenue of ₹1.60 Cr (FY 2025).

DIN 08544123
Primary Designation Director
Industry Healthcare
First Appointment 22 Aug 2019
Oldest Company Age 7 yrs
Largest company Flokem Pharma Private Limited · ₹1.60 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flokem Pharma Private Limited U33100MH2019PTC329653
Director22 Aug 20192019₹1.60 Cr (FY 2025)Active

Board colleagues of Urvi Manish Kothari

NameDINCompanyDesignation
Manish Dilip Kothari02755871Flokem Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Flokem Pharma Private Limited
Premium access

Shareholding and investment profile for Urvi Manish Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urvi Manish Kothari

Urvi Manish Kothari currently holds 1 directorship: Flokem Pharma Private Limited (Director, since 22 Aug 2019, revenue ₹1.60 Cr (FY 2025)).

Urvi Manish Kothari was first appointed on 22 Aug 2019 as Director at Flokem Pharma Private Limited.

The current boards of Urvi Manish Kothari's companies include Manish Dilip Kothari (Flokem Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available